BioWorld Asia

Feb. 11, 2004

Ark Seeks Listing On London Stock Exchange Via £50 IPO

LONDON - Ark Therapeutics Group plc is feeling out investor appetite for what would be the first listing of a biotechnology company on the main market of the London Stock Exchange in three years. (BioWorld International) Read More

CAT Reports CAT-192 Results With Genzyme, Ends Elan Deal

Structure Of 1918 Flu Virus Holds Clue To Its Virulence

Hurdles For Europe Include Tissue Engineering, Patents

Advancements In SiRNA Spur Strategy Change For Atugen

BiondVax Raises $4M For Multiseason Nasal Vaccine

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for March 11, 2026.

Microscopic image of clear cell carcinoma, the most common type of renal cell carcinoma.

Cas and effect: Merck’s phase III ripples HIF-2α space

BioWorld

Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...

Tanycytes in green capturing tau protein in red.

Brain’s hidden tau-clearing pathway uncovered

BioWorld Science

Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...

News in brief

BioWorld Asia

BioWorld Asia briefs for March 10, 2026

MSD synthesizes α-synuclein PET agents

BioWorld Science

Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...